Roy Davee, MD
Gastroenterology · Houston, TXNPI 1184911273
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,190 of the $26,872 with a category attached, or 71.4%. Medical Device Business Services, Inc. accounts for 78.0% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2022 at $16,833 and has fallen 96.4% since, to $612 in 2025. Among gastroenterology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 107 payments — averaging $251.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$21K
- Boston Scientific$2K
- Conmed Corporation$761
- Johnson & Johnson$485
- Medtronic$436
- AbbVie$380
- plus $2K from 19 others
What the payments were for
- Consulting fees$19,19071%
- Travel & lodging$1,4535%
- Food & beverage$6,23023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 16 | $20,971 |
| Boston Scientific | 28 | $1,915 |
| Conmed Corporation | 12 | $761 |
| Johnson & Johnson(2 entities) | 6 | $485 |
| Medtronic | 4 | $436 |
| AbbVie | 6 | $380 |
| Apollo Endosurgery US Inc | 4 | $295 |
| Endogastric Solutions, Inc | 5 | $241 |
| Madrigal Pharmaceuticals | 4 | $225 |
| Covidien LP | 4 | $210 |
| Olympus America Inc. | 2 | $183 |
| Steris Corporation | 1 | $167 |
| Pentax Of America, Inc. | 1 | $118 |
| Pfizer | 1 | $105 |
| Cook Medical LLC | 2 | $98 |
| Lumendi LLC | 1 | $52 |
| Ambu Inc. | 2 | $47 |
| ERBE USA Inc | 1 | $34 |
| Alcresta Therapeutics, Inc. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Bristol Myers Squibb | 1 | $20 |
| Regeneron | 1 | $19 |
| Sanofi | 1 | $19 |
| Aries Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LINX Reflux Management System$471
- GENERAL - THERAPIES$405
- Creon$293
- TRUFREEZE$167
- CONMED BILIARY$158
- REZDIFFRA$147
- OverStitch Endoscopic Suturing System$146
- INTERSTIM$139
- NEXPOWDER$136
- INSPIRA$118
- ESOPHYX$113
- RESOLUTION CLIP$112
- VELSIPITY$105
- ACQUIRE$105
- CONMED GENERATORS$102
- Beacon$101
How this compares
$26,872 in reported general payments places this provider in the 90th percentile of 1,350 gastroenterology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 23 | $29,328 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 38 | $2,048 |
| Omeprazole | 58 | $743 |
| Pantoprazole Sodium | 41 | $474 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 28 | $312 |
| Dicyclomine Hcl | 15 | $162 |
| Esomeprazole Magnesium | 14 | $158 |
| Ondansetron Hcl | 12 | $140 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $380 | $29,32823 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,350 gastroenterology providers in Texas.
Other gastroenterology in Houston
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Brooks CashHouston$867K
- Mohamed OthmanHouston$777K
- Isaac RaijmanHouston$565K
- Kalpesh PatelHouston$382K
- Victor Ankoma-SeyHouston$340K
- John VierlingHouston$270K
- George TriadafilopoulosHouston$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.